Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis
Pakistan Journal of Medical Sciences · 05.03.2026 · 42 (3) · 599-603
DOI: 10.12669/pjms.42.3.12534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 05.03.2026. Verfasst von Bader Faiyaz Zuberi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bader Faiyaz Zuberi, FCPS. Meritorious Professor, OMI Hospital, Karachi, Sindh, Pakistan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To determine on-treatment changes in MELD-Na & Fibroscan scores after a period of six months in patients with chronic Hepatitis-B who are treated with Entecavir (ETV). Methodology: This observational cohort was conducted at Department of Medicine/Gastroenterology, Dow Medical College affiliated with Dow University of Health Sciences, Karachi, Pakistan during the period of August 2019 to December 2024. Patients of either gender aged between 18 - 80 years attending hepatitis clinic and who are on treatment for Hepatitis-B with Entecavir were inducted after informed consent. MELD-Na & Fibroscan scores were recorded at induction and after six months of treatment with ETV.
Results
A total of 288 patients were enrolled including 153 (53.1%) were males with mean age of 37.6 ±11.6 years and 135 (46.9%) were females with mean age of 43.5 ±9.6 years. The difference in age between genders was significant (p < .001). Comparison of parameters at induction of study and after six months of treatment with Entecavir using Paired Sample T-Test, we found significant improvement in all parameters except serum albumin which showed significant reduction in levels after six months. MELD-Na Score improved from 9.38 to 8.94 (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bader Faiyaz Zuberi, FCPS. Meritorious Professor, OMI Hospital, Karachi, Sindh, Pakistan.
- Faiza Sadaqat Ali, FCPS Senior Registrar, Department of Medicine/Gastroenterology, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
- Tazeen Rasheed, FCPS Associate Professor, Department of Medicine/Gastroenterology, Dow University of Health Sciences, Karachi, Sindh, Pakistan.
- Nimrah Bader, MD Assistant Professor, Department of Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA.
Zitieren
APA
Zuberi, B. F., Ali, F. S., Rasheed, T., & Bader, N. (2026). Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. Pakistan Journal of Medical Sciences, 42(3), 599-603. https://doi.org/10.12669/pjms.42.3.12534
Vancouver
Zuberi BF, Ali FS, Rasheed T, Bader N. Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. Pakistan Journal of Medical Sciences. 2026;42(3):599-603. doi:10.12669/pjms.42.3.12534
BibTeX
@article{Zuberi2026,
author = {Zuberi, Bader Faiyaz and Ali, Faiza Sadaqat and Rasheed, Tazeen and Bader, Nimrah},
title = {Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis},
journal = {Pakistan Journal of Medical Sciences},
year = {2026},
volume = {42},
number = {3},
pages = {599--603},
doi = {10.12669/pjms.42.3.12534}
}
EUVIMED